Blocking the CXXC5-Dvl interaction can improve the disease metabolic status of mice, reduce insulin resistance, inhibit adipocyte differentiation, facilitate the regeneration of pancreatic beta-cells, and enhance glucose homeostasis [71, 83]. The gene discussed is CXXC5; the disease is Insulin resistance.